 | • レポートコード：QYR2104Z4686 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ポイントオブケア感染症診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HIV POC、クロストリジウムディフィシルPOC、HBV POC、呼吸器合胞体ウイルスPOC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TB＆薬剤耐性TB POC）、用途別市場規模（病院、診療所、自宅、生活支援医療施設、研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ポイントオブケア感染症診断の市場動向 ・企業の競争状況、市場シェア ・ポイントオブケア感染症診断の種類別市場規模（HIV POC、クロストリジウムディフィシルPOC、HBV POC、呼吸器合胞体ウイルスPOC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TB＆薬剤耐性TB POC） ・ポイントオブケア感染症診断の用途別市場規模（病院、診療所、自宅、生活支援医療施設、研究所、その他） ・ポイントオブケア感染症診断の北米市場規模2016-2027（アメリカ、カナダ） ・ポイントオブケア感染症診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ポイントオブケア感染症診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ポイントオブケア感染症診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・ポイントオブケア感染症診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Abbott、Calypte Biomedical、Chembio Diagnostic Systems、Meridian Bioscience、MedMira、Trinity Biotech、Sekisui Diagnostics、OraSure Technologies、Quidel） ・結論 |
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric services and escalating incidence rates of complicated infectious disorders.
Market Analysis and Insights: Global Point-of-care Infectious Disease Diagnostics Market
The global Point-of-care Infectious Disease Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point-of-care Infectious Disease Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point-of-care Infectious Disease Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point-of-care Infectious Disease Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point-of-care Infectious Disease Diagnostics market.
Global Point-of-care Infectious Disease Diagnostics Scope and Market Size
Point-of-care Infectious Disease Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Point-of-care Infectious Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
HIV POC
Clostridium Difficile POC
HBV POC
Respiratory Syncytial Virus POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and Drug-Resistant TB POC
Segment by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Abbott
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HIV POC
1.2.3 Clostridium Difficile POC
1.2.4 HBV POC
1.2.5 Respiratory Syncytial Virus POC
1.2.6 HPV POC
1.2.7 Influenza/Flu POC
1.2.8 HCV POC
1.2.9 MRSA POC
1.2.10 TB and Drug-Resistant TB POC
1.3 Market by Application
1.3.1 Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2016-2027)
2.2 Point-of-care Infectious Disease Diagnostics Growth Trends by Regions
2.2.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Point-of-care Infectious Disease Diagnostics Industry Dynamic
2.3.1 Point-of-care Infectious Disease Diagnostics Market Trends
2.3.2 Point-of-care Infectious Disease Diagnostics Market Drivers
2.3.3 Point-of-care Infectious Disease Diagnostics Market Challenges
2.3.4 Point-of-care Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue
3.4 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2020
3.5 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Point-of-care Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027)
5 Point-of-care Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2016-2027)
6.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Type
6.2.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027)
6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Application
6.3.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027)
6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Country
6.4.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2016-2027)
7.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type
7.2.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027)
7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application
7.3.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027)
7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country
7.4.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type
8.2.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application
8.3.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region
8.4.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size (2016-2027)
9.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type
9.2.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application
9.3.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country
9.4.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type
10.2.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application
10.3.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country
10.4.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction
11.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Calypte Biomedical
11.3.1 Calypte Biomedical Company Details
11.3.2 Calypte Biomedical Business Overview
11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction
11.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.3.5 Calypte Biomedical Recent Development
11.4 Chembio Diagnostic Systems
11.4.1 Chembio Diagnostic Systems Company Details
11.4.2 Chembio Diagnostic Systems Business Overview
11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction
11.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.4.5 Chembio Diagnostic Systems Recent Development
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Details
11.5.2 Meridian Bioscience Business Overview
11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction
11.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.5.5 Meridian Bioscience Recent Development
11.6 MedMira
11.6.1 MedMira Company Details
11.6.2 MedMira Business Overview
11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction
11.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.6.5 MedMira Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Details
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction
11.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.7.5 Trinity Biotech Recent Development
11.8 Sekisui Diagnostics
11.8.1 Sekisui Diagnostics Company Details
11.8.2 Sekisui Diagnostics Business Overview
11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction
11.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.8.5 Sekisui Diagnostics Recent Development
11.9 OraSure Technologies
11.9.1 OraSure Technologies Company Details
11.9.2 OraSure Technologies Business Overview
11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction
11.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.9.5 OraSure Technologies Recent Development
11.10 Quidel
11.10.1 Quidel Company Details
11.10.2 Quidel Business Overview
11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction
11.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
11.10.5 Quidel Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HIV POC
Table 3. Key Players of Clostridium Difficile POC
Table 4. Key Players of HBV POC
Table 5. Key Players of Respiratory Syncytial Virus POC
Table 6. Key Players of HPV POC
Table 7. Key Players of Influenza/Flu POC
Table 8. Key Players of HCV POC
Table 9. Key Players of MRSA POC
Table 10. Key Players of TB and Drug-Resistant TB POC
Table 11. Global Point-of-care Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Point-of-care Infectious Disease Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Point-of-care Infectious Disease Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions (2016-2021)
Table 15. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions (2022-2027)
Table 17. Point-of-care Infectious Disease Diagnostics Market Trends
Table 18. Point-of-care Infectious Disease Diagnostics Market Drivers
Table 19. Point-of-care Infectious Disease Diagnostics Market Challenges
Table 20. Point-of-care Infectious Disease Diagnostics Market Restraints
Table 21. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Point-of-care Infectious Disease Diagnostics Market Share by Players (2016-2021)
Table 23. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2020)
Table 24. Ranking of Global Top Point-of-care Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
Table 28. Date of Enter into Point-of-care Infectious Disease Diagnostics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021)
Table 32. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Point-of-care Infectious Disease Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2016-2021)
Table 36. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product
Table 71. Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Point-of-care Infectious Disease Diagnostics Product
Table 76. Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Calypte Biomedical Company Details
Table 79. Calypte Biomedical Business Overview
Table 80. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product
Table 81. Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Calypte Biomedical Recent Development
Table 83. Chembio Diagnostic Systems Company Details
Table 84. Chembio Diagnostic Systems Business Overview
Table 85. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product
Table 86. Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Chembio Diagnostic Systems Recent Development
Table 88. Meridian Bioscience Company Details
Table 89. Meridian Bioscience Business Overview
Table 90. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product
Table 91. Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Meridian Bioscience Recent Development
Table 93. MedMira Company Details
Table 94. MedMira Business Overview
Table 95. MedMira Point-of-care Infectious Disease Diagnostics Product
Table 96. MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 97. MedMira Recent Development
Table 98. Trinity Biotech Company Details
Table 99. Trinity Biotech Business Overview
Table 100. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product
Table 101. Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 102. Trinity Biotech Recent Development
Table 103. Sekisui Diagnostics Company Details
Table 104. Sekisui Diagnostics Business Overview
Table 105. Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Sekisui Diagnostics Recent Development
Table 107. OraSure Technologies Company Details
Table 108. OraSure Technologies Business Overview
Table 109. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product
Table 110. OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 111. OraSure Technologies Recent Development
Table 112. Quidel Company Details
Table 113. Quidel Business Overview
Table 114. Quidel Point-of-care Infectious Disease Diagnostics Product
Table 115. Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Quidel Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-care Infectious Disease Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. HIV POC Features
Figure 3. Clostridium Difficile POC Features
Figure 4. HBV POC Features
Figure 5. Respiratory Syncytial Virus POC Features
Figure 6. HPV POC Features
Figure 7. Influenza/Flu POC Features
Figure 8. HCV POC Features
Figure 9. MRSA POC Features
Figure 10. TB and Drug-Resistant TB POC Features
Figure 11. Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2020 VS 2027
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. Home Case Studies
Figure 15. Assisted Living Healthcare Facilities Case Studies
Figure 16. Laboratories Case Studies
Figure 17. Others Case Studies
Figure 18. Point-of-care Infectious Disease Diagnostics Report Years Considered
Figure 19. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 20. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 21. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions: 2020 VS 2027
Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions (2022-2027)
Figure 23. Global Point-of-care Infectious Disease Diagnostics Market Share by Players in 2020
Figure 24. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2020
Figure 25. The Top 10 and 5 Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue in 2020
Figure 26. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021)
Figure 27. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027)
Figure 28. North America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. North America Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 30. North America Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 31. North America Point-of-care Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 32. United States Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Canada Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Europe Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 36. Europe Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 37. Europe Point-of-care Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 38. Germany Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. France Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. U.K. Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Italy Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Russia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Nordic Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 46. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 47. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Region (2016-2027)
Figure 48. China Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Japan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. South Korea Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. India Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Australia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 56. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 57. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 58. Mexico Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Brazil Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 62. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 63. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 64. Turkey Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Saudi Arabia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. UAE Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 68. Abbott Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 69. Calypte Biomedical Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 70. Chembio Diagnostic Systems Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 71. Meridian Bioscience Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 72. MedMira Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 73. Trinity Biotech Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 74. Sekisui Diagnostics Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 75. OraSure Technologies Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 76. Quidel Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界のポイントオブケア感染症診断/検査市場 2021：企業別、地域別、種類・用途別 The Point-of-Care Infectious Disease Diagnostics/Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…- 世界の感染症用ポイントオブケア検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Point of Care Testing for Infectious Disease Market The global Point of Care Testing for Infectious Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の感染症ポイントオブケア（POCT）検査市場 2021：企業別、地域別、種類・用途別 The Point of Care Testing for Infectious Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の感染症診断市場規模・現状・予測（2021年-2027年） Infectious-disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. Market Analysis and Insights: Global Infectious Disease Diagnostics Market The global Infectious Disease Diagnostics market size is projected to reach US$ 1687…
- 世界の呼吸器合胞体ウイルス（RSV）診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Syncytial Virus (RSV) Diagnostics Market The global Respiratory Syncytial Virus (RSV) Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…